Effect of cognitive-existential group intervention in patients with gastric cancer undergoing chemotherapy after radical gastrectomy
10.3760/cma.j.cn115682-20220312-01156
- VernacularTitle:认知-存在团体干预在胃癌根治术后化疗患者中的应用
- Author:
Dong DONG
1
;
Shujue CHEN
Author Information
1. 无锡市第二人民医院B9骨科消化肿瘤科，无锡 214000
- Keywords:
Stomach neoplasms;
Cognitive-existential group intervention;
Drug therapy;
Fear of disease progression;
Hope;
Psychology
- From:
Chinese Journal of Modern Nursing
2023;29(3):370-374
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of cognitive-existential group intervention in patients with gastric cancer undergoing chemotherapy after radical gastrectomy.Methods:From September 2020 to September 2021, 80 patients with gastric cancer who received chemotherapy in the Department of Digestive Oncology of the Wuxi Second People's Hospital were selected by the convenient sampling. The patients were divided into the observation group and the control group with 40 cases each by using the random number table. The control group received routine postoperative chemotherapy nursing, while the observation group received cognitive-existential group intervention on the basis of the control group. The intervention effects of the two groups were compared with the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) , Herth Hope Index (HHI) , Distress Thermometer (DT) , and Connor-Davidson Resilience Scale (CD-RISC) .Results:After intervention, FoP-Q-SF and DT scores in the observation group were lower than those in the control group, with statistically significant differences ( P<0.05) . After intervention, HHI and CD-RISC scores in the observation group were statistically higher than those in the control group ( P<0.05) . Conclusions:Cognitive-existential group intervention can effectively reduce the fear of disease progression and psychological pain of gastric cancer patients with chemotherapy after radical gastrectomy, and improve their hope and psychological resilience, which is worthy of clinical promotion.
